Jorge Barrios‐Payán

1.4k total citations
68 papers, 971 citations indexed

About

Jorge Barrios‐Payán is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Jorge Barrios‐Payán has authored 68 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 27 papers in Immunology and 21 papers in Epidemiology. Recurrent topics in Jorge Barrios‐Payán's work include Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (14 papers) and Immune Response and Inflammation (10 papers). Jorge Barrios‐Payán is often cited by papers focused on Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (14 papers) and Immune Response and Inflammation (10 papers). Jorge Barrios‐Payán collaborates with scholars based in Mexico, Argentina and Spain. Jorge Barrios‐Payán's co-authors include Rogélio Hernández‐Pando, Dulce Mata‐Espinosa, Brenda Marquina‐Castillo, Alejandro Francisco‐Cruz, Mauricio Castañón-Arreola, Milena Saqui–Salces, Miguel Aguilar‐Santelises, G.A.W. Rook, Mangalakumari Jeyanathan and Mario Alberto Flores‐Valdez and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jorge Barrios‐Payán

64 papers receiving 957 citations

Peers

Countries citing papers authored by Jorge Barrios‐Payán

Since Specialization

Citations

This map shows the geographic impact of Jorge Barrios‐Payán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Barrios‐Payán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Barrios‐Payán more than expected).

Fields of papers citing papers by Jorge Barrios‐Payán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Barrios‐Payán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Barrios‐Payán. The network helps show where Jorge Barrios‐Payán may publish in the future.

Co-authorship network of co-authors of Jorge Barrios‐Payán

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Barrios‐Payán. A scholar is included among the top collaborators of Jorge Barrios‐Payán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Barrios‐Payán. Jorge Barrios‐Payán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fitness costs of Mycobacterium tuberculosis resistant to rifampicin is compensated by rapid Th2 polarization mediated by early and high IL-4 production during mice infection 2025 ·Scientific Reports ·(unknown), (unknown), Dulce Mata‐Espinosa, Jorge Barrios‐Payán, Hugo G. Castelán‐Sánchez, Sofía Lizeth Alcaráz‐Estrada, Mauricio Castañón-Arreola, Rogélio Hernández‐Pando	1
2	The Plasma Membrane P-Type ATPase CtpA Is Required for Mycobacterium tuberculosis Virulence in Copper-Activated Macrophages in a Mouse Model of Progressive Tuberculosis 2025 ·Biomedicines ·(unknown), Jorge Barrios‐Payán, (unknown), Rogélio Hernández‐Pando, Marisol Ocampo, Carlos Y. Soto, Dulce Mata‐Espinosa	0
3	BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice 2023 ·Vaccine ·(unknown), Jorge Barrios‐Payán, (unknown), Mario Alberto Flores‐Valdez, Dulce Mata‐Espinosa, (unknown), (unknown), Deepak Kumar Saini, (unknown), Miguel A. Ares, Helle Bielefeldt‐Ohmann, Guillermina Baay-Guzmán, Isabelle Vergne, Jesús Bernardino Velázquez-Fernández, Jeannette Barba‐León, Rogélio Hernández‐Pando	5
4	Baculovirus-mediated expression of a Helicobacter pylori protein-based multiepitope hybrid gene induces a potent B cell response in mice 2023 ·Immunobiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Barrios‐Payán, (unknown), Laura A. Palomares, Fernando Esquivel‐Guadarrama, Efraín Garrido, (unknown)	0
5	The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis 2023 ·Pharmaceuticals ·Dulce Mata‐Espinosa, (unknown), Jorge Barrios‐Payán, Rogélio Hernández‐Pando	3
6	Thymic atrophy induced by Plasmodium berghei ANKA and Plasmodium yoelii 17XL infection 2023 ·Immunology Letters ·(unknown), (unknown), (unknown), Ismael Mancilla‐Herrera, Jorge Barrios‐Payán, (unknown), Rogélio Hernández‐Pando, Luvia Enid Sánchez‐Torres	2
7	In Vitro, In Vivo and In Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis 2022 ·Antibiotics ·(unknown), Jorge Barrios‐Payán, Dulce Mata‐Espinosa, (unknown), Juan Carlos León‐Contreras, Gerald H. Lushington, Tonatiuh Melgarejo, Rogélio Hernández‐Pando	2
8	16α-Bromoepiandrosterone as a new candidate for experimental diabetes–tuberculosis co-morbidity treatment 2021 ·Clinical & Experimental Immunology ·(unknown), Brenda Marquina‐Castillo, (unknown), Dulce Mata‐Espinosa, Jorge Barrios‐Payán, Guillermina Baay-Guzmán, Sara Huerta‐Yépez, Estela Isabel Bini, Iván Torre-Villalvazo, Nimbe Torres, Armando R. Tovar, William Chamberlin, (unknown), Andrea Carranza, Rogélio Hernández‐Pando	12
9	Monocyte Locomotion Inhibitory Factor confers neuroprotection and prevents the development of murine cerebral malaria 2021 ·International Immunopharmacology ·(unknown), (unknown), (unknown), (unknown), Raúl Silva‐García, Brenda Marquina‐Castillo, Juan Carlos León‐Contreras, Jorge Barrios‐Payán, Alejandro Francisco‐Cruz, (unknown), Sara Huerta‐Yépez, Juana Calderón‐Amador, Leopoldo Flores‐Romo, Rogélio Hernández‐Pando, Luvia Enid Sánchez‐Torres	4
10	Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis 2021 ·Metabolites ·(unknown), Luis M. Peña-Rodrı́guez, (unknown), Jorge Bórquez, Mario J. Simirgiotis, Hugo Barrios-García, Rogélio Hernández‐Pando, Luis Loyola, Carlos Areche, (unknown), Jorge Barrios‐Payán, Dulce Mata‐Espinosa, Fabiola Escalante‐Erosa, Karlina García‐Sosa, Gloria María Molina‐Salinas	2
11	The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary Tuberculosis 2021 ·Frontiers in Immunology ·(unknown), Brenda Marquina‐Castillo, Dulce Mata‐Espinosa, (unknown), Jaime Chávez, Luciana Balboa, (unknown), (unknown), Jorge Barrios‐Payán, Rogélio Hernández‐Pando	9
12	Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines 2020 ·npj Vaccines ·(unknown), Brenda Marquina‐Castillo, (unknown), Dulce Mata‐Espinosa, Jorge Barrios‐Payán, (unknown), (unknown), Helle Bielefeldt‐Ohmann, Rogélio Hernández‐Pando, Mario Alberto Flores‐Valdez	2
13	<p>Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis</p> 2019 ·International Journal of Nanomedicine ·(unknown), (unknown), (unknown), (unknown), Miguel Ángel Ibáñez-Hernández, Luvia Enid Sánchez‐Torres, Jorge Barrios‐Payán, Dulce Mata‐Espinosa, Sergio Estrada‐Parra, Rommel Chacón‐Salinas, Jeanet Serafín‐López, Isabel Wong‐Baeza, Rogélio Hernández‐Pando, Iris Estrada‐García	22
14	Titanium dioxide nanofibers induce angiogenic markers and genomic instability in lung cells leading to a highly dedifferentiated and fibrotic tumor formation in a xenograft model 2018 ·Environmental Science Nano ·Estefany I. Medina‐Reyes, Norma L. Delgado‐Buenrostro, Alejandro Déciga‐Alcaraz, Verónica Freyre‐Fonseca, José O. Flores–Flores, Rogélio Hernández‐Pando, Jorge Barrios‐Payán, Julio César Carrero, Yesennia Sánchez-Pérez, Claudia M. García-Cuéllar, Felipe Vaca‐Paniagua, Yolanda I. Chirino	7
15	Trypanosoma cruzi High Mobility Group B (TcHMGB) can act as an inflammatory mediator on mammalian cells 2017 ·PLoS neglected tropical diseases ·Pamela Cribb, (unknown), Victoria Lucía Alonso, (unknown), Jorge Barrios‐Payán, Brenda Marquina‐Castillo, (unknown), Rogélio Hernández‐Pando	6
16	Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis 2017 ·Vaccine ·(unknown), Jorge Barrios‐Payán, Dulce Mata‐Espinosa, Sergio Sánchez, Rogélio Hernández‐Pando, Romina Rodríguez‐Sanoja	9
17	The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo 2016 ·Vaccine ·(unknown), (unknown), Jorge Barrios‐Payán, Dulce Mata‐Espinosa, (unknown), Brenda Marquina‐Castillo, Rogélio Hernández‐Pando, Mario Alberto Flores‐Valdez	27
18	The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis 2015 ·PLoS ONE ·Rogélio Hernández‐Pando, Jorge Barrios‐Payán, Dulce Mata‐Espinosa, Brenda Marquina‐Castillo, Diego F. Hernández‐Ramírez, (unknown), Estela Isabel Bini	18
19	Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor 2013 ·Medical Oncology ·Alejandro Francisco‐Cruz, Miguel Aguilar‐Santelises, (unknown), Dulce Mata‐Espinosa, Brenda Marquina‐Castillo, Jorge Barrios‐Payán, Rogélio Hernández‐Pando	102
20	Aspectos biológicos, clínicos y epidemiológicos de la tuberculosis latente: Biological, clinical and epidemiological aspects of latent tuberculosis 2010 ·Salud Pública de México ·Jorge Barrios‐Payán, Mauricio Castañón-Arreola, Mario Alberto Flores‐Valdez, Rogélio Hernández‐Pando	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact